CL1 – UBS rates the stock as Buy
The company reported a “reasonable” March quarter, UBS suggests, with 2,000 net Class Super accounts added. The rate of net additions was above the December quarter but well below prior periods. The company continues to highlight regulatory and political uncertainty.
Read More